Kraig Biocraft Labs Stock Last Dividend Paid
| KBLB Stock | USD 0.09 0.00 0.00% |
Kraig Biocraft Labs fundamentals help investors to digest information that contributes to Kraig Biocraft's financial success or failures. It also enables traders to predict the movement of Kraig OTC Stock. The fundamental analysis module provides a way to measure Kraig Biocraft's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Kraig Biocraft otc stock.
Kraig |
Kraig Biocraft Labs OTC Stock Last Dividend Paid Analysis
Kraig Biocraft's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
| Competition |
Based on the recorded statements, Kraig Biocraft Labs has a Last Dividend Paid of 0.0. This indicator is about the same for the Chemicals average (which is currently at 0.0) sector and about the same as Materials (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Bond Analysis Now
Bond AnalysisEvaluate and analyze corporate bonds as a potential investment for your portfolios. |
| All Next | Launch Module |
Kraig Fundamentals
| Return On Asset | -0.32 | |||
| Current Valuation | 34.14 M | |||
| Shares Outstanding | 1.02 B | |||
| Shares Owned By Insiders | 25.29 % | |||
| Shares Owned By Institutions | 0.01 % | |||
| Price To Earning | (9.37) X | |||
| Price To Sales | 1,199 X | |||
| EBITDA | (2.64 M) | |||
| Net Income | (8.05 M) | |||
| Cash And Equivalents | 4.82 M | |||
| Total Debt | 95.24 K | |||
| Current Ratio | 0.53 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (1.8 M) | |||
| Earnings Per Share | (0.01) X | |||
| Number Of Employees | 38 | |||
| Beta | 0.34 | |||
| Market Capitalization | 38.03 M | |||
| Total Asset | 3.02 M | |||
| Retained Earnings | (22.47 M) | |||
| Working Capital | (2.32 M) | |||
| Current Asset | 356 K | |||
| Current Liabilities | 2.68 M | |||
| Net Asset | 3.02 M |
About Kraig Biocraft Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kraig Biocraft Labs's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kraig Biocraft using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kraig Biocraft Labs based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Kraig OTC Stock
Kraig Biocraft financial ratios help investors to determine whether Kraig OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kraig with respect to the benefits of owning Kraig Biocraft security.